Case Report
A Peculiar Cause of Shock: Analysing Two Clinical Cases
Figure 3
Case 1 clinical and analytical evolution. Case 1 analytical evolution of cardiac necrosis markers and inflammatory markers. The patient was under ECMO between the 2nd and 10th days, hemodialysis between the 2nd and 12th days, and mechanical ventilation until the 8th day. She was treated with 14 days of effective antibiotic therapy 2 days of piperacillin and tazobactam and 12 days of amoxicillin/clavulanate. BNP: B natriuretic peptide; CK-MB: creatine kinase-myocardial band; CRP: C-reactive protein; Leuk: leucocytes. In the first days in the ICU, two blood sample analyses were performed daily, which are depicted in the graph as morning () and evening (). For graphical coherence, the troponin and myoglobin level scale is at a tenth of the real value.